Evidence map›Paper›PMID 25875470›Full record

ArticlePloS one2015

Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.

Mauro P Avanzi, Marina Izak, Oluwasijibomi E Oluwadara, William Beau Mitchell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Immune attack on megakaryocytes in immune thrombocytopenia.Research and practice in thrombosis and haemostasis · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mauro P AvanziPlatelet Biology Laboratory, New York Blood Center, New York, New York, United States of America.
Marina IzakPlatelet Biology Laboratory, New York Blood Center, New York, New York, United States of America.
Oluwasijibomi E OluwadaraPlatelet Biology Laboratory, New York Blood Center, New York, New York, United States of America.
William Beau MitchellPlatelet Biology Laboratory, New York Blood Center, New York, New York, United States of America.
New York Blood Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMegakaryocytes assemble and release platelets through the extension of proplatelet processes, which are cytoplasmic extensions that extrude from the megakaryocyte and form platelets at their tips. Proplatelet formation and platelet release are complex processes that require a combination of structural rearrangements. While the signals that trigger the initiation of proplatelet formation process are not completely understood, it has been shown that inhibition of cytoskeletal signaling in mature megakaryocytes induces proplatelet formation. Megakaryocyte apoptosis may also be involved in initiation of proplatelet extension, although this is controversial. This study inquires whether the proplatelet production induced by cytoskeletal signaling inhibition is dependent on activation of apoptosis.

methodsMegakaryocytes derived from human umbilical cord blood CD34+ cells were treated with the actin polymerization inhibitor latrunculin and their ploidy and proplatelet formation were quantitated. Apoptosis activation was analyzed by flow cytometry and luminescence assays. Caspase activity was inhibited by two compounds, ZVAD and QVD. Expression levels of pro-survival and pro-apoptosis genes were measured by quantitative RT-PCR. Protein levels of Bcl-XL, Bax and Bak were measured by western blot. Cell ultrastructure was analyzed by electron microscopy.

resultsActin inhibition resulted in increased ploidy and increased proplatelet formation in cultured umbilical cord blood-derived megakaryocytes. Actin inhibition activated apoptosis in the cultured cells. The effects of actin inhibition on proplatelet formation were blocked by caspase inhibition. Increased expression of both pro-apoptotic and pro-survival genes was observed. Pro-survival protein (Bcl-xL) levels were increased compared to levels of pro-apoptotic proteins Bak and Bax. Despite apoptosis being activated, the megakaryocytes underwent minimal ultrastructural changes during actin inhibition.

conclusionsWe report a correlation between increased proplatelet formation and activation of apoptosis, and that the increase in proplatelet formation in response to actin inhibition is caspase dependent. These findings support a role for apoptosis in proplatelet formation in this model.

Indexed as

ApoptosisActinsAmino Acid Chloromethyl Ketonesbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer Proteinbcl-X ProteinBlood PlateletsBridged Bicyclo Compounds, HeterocyclicCaspasesCells, CulturedFetal BloodHumansMegakaryocytesMicroscopy, Electron, TransmissionMicroscopy, FluorescencePolyploidyActinsAmino Acid Chloromethyl Ketonesbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer Proteinbcl-X Proteinbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneBridged Bicyclo Compounds, HeterocyclicCaspaseslatrunculin AQuinolinesquinoline-val-asp(OMe)-CH2-OPHThiazolidines

Identifiers

PMID25875470
PMCPMC4397066
OpenAlexW2054543912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.